Jason Butler
Analyst
Citizens JMP
Equibles does not estimate personal net worth.
About Jason Butler
Jason Butler is recorded as Analyst at Citizens JMP. Jason Butler has spoken on 11 earnings calls and 3 other investor events across 6 companies, most recently for CorMedix Inc. on November 12, 2026. Those appearances were for Halozyme Therapeutics, Inc. (HALO), PolyPid Ltd. (PYPD), Ironwood Pharmaceuticals Inc (IRWD), CorMedix Inc. (CRMD), Zevra Therapeutics, Inc. (ZVRA) and 1 other company. The companies whose calls Jason Butler spoke on are classified in the Healthcare sector.
Jason Butler on recent calls
“First, can you talk a little bit more about what you're doing to prepare for the Rosio profi launch? What is awareness of the product and the profi data now among potential prescribers?”
“Helen, now that you're several quarters past the last two acquisitions, what do you think your capacity is to bring in more synergistic technologies and what's your, you know, kind of perspective on priority there?”
“One question for the company and then I have a couple for Dr. Joseph. Deco, can you maybe talk about the preclinical data you have generated so far and any data you have around the PK profile?”
“First one, when you think about the 2029 and after enhanced product profile, what do you expect to be the biggest products in that portfolio? And then when are they coming to essentially peak in your model?”
Affiliation history
-
Citizens JMP
Analyst
Transcript header (unverified)
Current
Company network
PolyPid Ltd.
PYPD
Biotechnology · Healthcare
2 appearances
Latest appearance 2026-10-28
View calls and events
Drug Manufacturers - Specialty & Generic · Healthcare
2 appearances
Latest appearance 2026-05-07
View calls and events
CorMedix Inc.
CRMD
Biotechnology · Healthcare
1 appearance
Latest appearance 2026-11-12
View calls and events